First Time Loading...
C

Cyclopharm Ltd
ASX:CYC

Watchlist Manager
Cyclopharm Ltd
ASX:CYC
Watchlist
Price: 1.75 AUD Market Closed
Updated: Apr 29, 2024

Cyclopharm Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cyclopharm Ltd
Net Income (Common) Peer Comparison

Comparables:
NTI
IPD
COH
OIL
EMV

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
C
Cyclopharm Ltd
ASX:CYC
Net Income (Common)
-AU$4.7m
CAGR 3-Years
8%
CAGR 5-Years
-166%
CAGR 10-Years
7%
Neurotech International Ltd
ASX:NTI
Net Income (Common)
-AU$7.8m
CAGR 3-Years
-66%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
ImpediMed Ltd
ASX:IPD
Net Income (Common)
-AU$19.4m
CAGR 3-Years
-1%
CAGR 5-Years
5%
CAGR 10-Years
-11%
Cochlear Ltd
ASX:COH
Net Income (Common)
AU$350.4m
CAGR 3-Years
N/A
CAGR 5-Years
6%
CAGR 10-Years
17%
Optiscan Imaging Ltd
ASX:OIL
Net Income (Common)
-AU$5.4m
CAGR 3-Years
-61%
CAGR 5-Years
-20%
CAGR 10-Years
-11%
EMvision Medical Devices Ltd
ASX:EMV
Net Income (Common)
-AU$3.9m
CAGR 3-Years
-4%
CAGR 5-Years
-36%
CAGR 10-Years
N/A

See Also

What is Cyclopharm Ltd's Net Income (Common)?
Net Income (Common)
-4.7m AUD

Based on the financial report for Dec 31, 2023, Cyclopharm Ltd's Net Income (Common) amounts to -4.7m AUD.

What is Cyclopharm Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
7%

Over the last year, the Net Income (Common) growth was 29%. The average annual Net Income (Common) growth rates for Cyclopharm Ltd have been 8% over the past three years , -166% over the past five years , and 7% over the past ten years .